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   1． Animal studies：
   d－cis－isomer of benzothiazepine derivative （CRD－401）， which exerts a stropg coronary vaso－
dilating effect， was confirmed to have weak or almost no hypotensive effect in the anesthetised
normal dog． However， when administered to the hypertensive dog induced by intravenous
infusion ot angiotensin II， CRD－401 caused prominent decrease of diastolic blood pressure and
restoration of renal blood flow accompanied by remarkable sodium diuresis．
   The effect was nonspecific since vasoconstricting responses to injected norepinephrine and
－stimulation of mesenteric nerves were also inhibited in dogs in which mesenteric vessels were
perfused in vivo． Phentolarnine inhibited dose－dependently response to norepinephrine， but
CRD－401 did not．
   The experiments suggest that CRD－401 has direct action on vascu／ar smooth muscle・and
cannot readily be classified into alpha or beta adrenergic blocking drugs．
   2． Clinical studies：
   CRD－401 was investigated by oral administration of 60－v90 mg per day in 26 patients with
hypertension associated with renal parenchymal disease and renovascular hypertension． Blood
pressure was lowered in two thirds of the patients． Within 2 to 4 days after the adrninistration，
blood pressure was reached the lowest level and then gradually returned to the control levels
after s’?魔?窒≠?weeks．
   Urinary sodium excretion was remarkably increased， and urine volume also increased but
at less extent． The changes were transient similarly to that of blood pressure．
   1－131－Hippuran clearance was elevated， although statistieally not significant． Endogenous
creatinine clearance did not change im皿ediately after the administration， but in some patients
there was transient increase and in others there was gradual increase．
   These renal ±unctional changes were also observed in those patients whose blood pressure
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was not lowered．
  Prelirninary results with oral administration suggest that CRD－401 would be a useful
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Fig． 2， Hemodynamic changes in the hypertensive dog induced by angiotensin II infusion．
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Table 1． Effects of CRD－401 on vasoconstrictor responses to norepinephrine and
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Each value shows perfusion pressure （mmHg） under the constant blood flow．
（概輿…黒礁娠綴）
         CRD－40／50㎎／勿／痂η．
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                     Dec．23
Fig．6．他剤併用例でのCRD－401の降圧効果を示す．
 上昇し，CRD－401で血圧はふたたび下降した．
          Feb，16
placeboに変えると血圧は直ちに
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Case：Y， N， 25 9一 R，Renal Arterjal Aneurysms
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注 1．CRD－401 infusion rate：20 mg／hr．
  2． Glucose infusion rate：200 ml／hr．
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Fig． 11．
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本論文の訂正＝Fig．4上段のグラフ中CRD－40150 mgを50μ9とします．
